Tetrahedral Framework Nucleic Acid Relieves Sepsis-Induced Intestinal Injury by Regulating M2 Macrophages

Tingting Tan1,2,3, Jiajie Li4, Wensi Fan1

  • 1Department of Critical Care Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Cell Proliferation
|January 23, 2025
PubMed

Insights

Tetrahedral framework nucleic acids (tFNAs) reduce intestinal injury by promoting M2 macrophage aggregation and enhancing gut barrier function. These findings offer a novel therapeutic strategy for treating sepsis-induced intestinal damage.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Gastroenterology

Background:

  • Sepsis-induced intestinal injury is a critical complication with significant mortality.
  • Modulating macrophage polarization, particularly towards the M2 phenotype, is a promising therapeutic avenue for tissue repair.

Purpose of the Study:

  • To elucidate the mechanism by which tetrahedral framework nucleic acids (tFNAs) regulate M2 macrophages to mitigate intestinal injury.
  • To evaluate the therapeutic potential of tFNAs in a mouse model of sepsis-induced intestinal injury.

Main Methods:

  • Establishment of a lipopolysaccharide (LPS)-induced mouse model of intestinal injury.
  • Assessment of inflammatory factors using qPCR and ELISA.
  • Evaluation of intestinal barrier integrity and permeability via Western blotting and immunohistochemistry.
  • Quantification and localization of macrophages using immunofluorescence.
  • Investigation of tFNAs' regulatory mechanisms on macrophages and inflammation through Western blotting.

Main Results:

  • tFNAs significantly attenuated sepsis-induced intestinal injury and promoted intestinal barrier reconstruction.
  • tFNAs enhanced M2 macrophage aggregation and M1 macrophage reduction in injured intestines.
  • tFNAs improved the clearance capacity of intestinal macrophages by activating STAT1 and SOCS1/3 pathways via Mertk receptor upregulation.

Conclusions:

  • tFNAs demonstrate a therapeutic effect on sepsis-induced intestinal injury by reprogramming macrophages towards an M2 phenotype.
  • tFNAs enhance intestinal barrier function and macrophage-mediated clearance, presenting a novel therapeutic strategy for intestinal injury.